Director/PDMR Shareholding

RNS Number : 8951E

Intelligent Ultrasound Group PLC

04 March 2020

 

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Company")

Director/PDMR Shareholding

Intelligent Ultrasound Group plc (AIM: MED), the ultrasound artificial intelligence (AI) software and simulation company, announces the following director share transactions.

The Company announces that Ian Whittaker, a Person Discharging Managerial Responsibilities of the Company ("PDMR"), transferred 374,982 Ordinary Shares in the Company for nil consideration on the 4^th March 2020 to a nominee account of which he is the beneficial owner.

Following this transaction, Ian Whittaker's interest and that of his persons closely associated in Ordinary Shares  remains unchanged at 374,982 Ordinary Shares of 1p representing 0.17% of the total issued share capital of the Company.

This notification relates to a transaction notified in accordance with the Market Abuse Regulation, further details below:

NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ian Whittaker
2	Reason for the notification
a)	Position/status	Chief Operating Officer, PDMR
b)	Initial notification/amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Full name of the entity	Intelligent Ultrasound Group plc
b)	Legal entity identifier code
4	Details of the transaction(s)
a)	Description of the financial instrument, type of instrument	Ordinary shares in Intelligent Ultrasound plc with a nominal value of 1 pence each
b)	Identification Code
c)	Nature of the transaction	Transfer to a nominee account
d)	Currency	GBP - British pound
e)	Price(s) and Volume(s)	N/A
f)	Aggregated information -  Price -  Volume -  Total	N/A
g)	Date of transaction	4th March 2020
h)	Place of transaction	Off market

Intelligent Ultrasound Group plc			www.intelligentultrasound.com
Stuart Gall, CEO  Helen Jones,  CFO			Tel: [phone]
Cenkos Securities - Nominated Advisor and broker			Tel:  [phone]
Giles Balleny / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR	Tel: [phone] or  [e-mail]
Anna Dunphy / Paul McManus		Mob: [phone] / Mob: [phone]

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: MED) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market.

Based in Cardiff and Oxford in the UK, Atlanta in the US and with representation in Beijing in Asia, the Group operates two divisions:

Clinical AI Division

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of protocol-based ultrasound scanning; and  AnatomyGuide, which aims to simplify ultrasound-guided needling by providing the user with real-time AI-based needle guidance software for a range of medical procedures.

Simulation Division

Focusses on hi-fidelity ultrasound education and training through simulation.  Its three main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator and the BodyWorks Eve Point of Care and Emergency Medicine training simulator. To date over 800 simulators have been sold to almost 500 medical institutions around the world.

www.intelligentultrasound.com  

 

END

 

 

DSHBUGDXGXGDGGX